The interaction between carbon nanotube and skin anti-cancer drugs: a DFT and NBO approach
Source abstract
Abstract
Nowadays, nanotubes are used widely as container agents to transport bioactive peptides, proteins, nucleic acids, and drugs, and used to deliver their cargos to cells and organs in human bodies. In this work, the possibility of the formation of stable composite between carbon nanotubes and skin anti-cancer drugs has been investigated. The nanotube used in this study includes 60 C atoms of (6,6) type. Density functional theory-based methods (B3LYP/6-31G) show that the composites between drugs (aminolevulinic acid and tretinoin) and nanotube are more stable than the single agents. The difference in the hybridization of C and O atoms can cause to a difference between bond lengths, angles, and charges. The natural bond orbital calculations indicate that some donor atoms (lone pair of oxygen or nitrogen atoms) can transfer electron to acceptor atoms ( σ * or π * in carbon nanotube) and the occupancy of the oxygen lone pair with increasing p orbital share of the lone pair electrons of oxygen decreases. Then, the highest occupied molecular orbital (HOMO) and the lowest unoccupied molecular orbital (LUMO), the HOMO-LUMO bandgap, and the electronic chemical potential ( μ ) for the lowest energy derived to estimate the structural stability of the composites have been investigated. Results show that nanotube-tretinoin is more stable than nanotube - aminolevulinic acid.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Carbon Nanotubes in Composites · Fullerene Chemistry and Applications · Nonlinear Optical Materials Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (28)
Show source-provided references
1. Lin J, Eder M, Weinmann S: Behavioral counseling to prevent skin cancer: a systematic review for the U.S. Preventive Services Task Force. Ann. Intern. Med 2011, 154: 190–201. 10.7326/0003-4819-154-3-201102010-0000910.7326/0003-4819-154-3-201102010-00009 ↗
2. Narayanan D, Saladi R, Fox J: Ultraviolet radiation and skin cancer. Int. J. Dermatol. 2010, 49: 978–986. 10.1111/j.1365-4632.2010.04474.x10.1111/j.1365-4632.2010.04474.x ↗
3. Sersa G, Miklavcic D, Cemazar M, Rudolf Z, Pucihar G, Snoj M: Electrochemotherapy in treatment of tumours. Eur. J. Surg. Oncol. 2008, 34: 232–240. 10.1016/j.ejso.2007.05.01610.1016/j.ejso.2007.05.016 ↗
4. Joensuu H: Systemic chemotherapy for cancer: from weapon to treatment. Lancet Oncol 2008, 9: 304. 10.1016/S1470-2045(08)70075-510.1016/S1470-2045(08)70075-5 ↗
5. Sanz M: Treatment of acute promyelocytic leukemia. Hematol. Am. Soc. Hematol. Educ. Progr 2006, 147–155.
6. Loureiro K, Kao K, Jones K, Alvarado S, Chavez C, Dick L, Felix R, Johnson D, Chambers C: Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy. Am. J. Med. Genet. A 2005, 136: 117–121.10.1002/ajmg.a.30744 ↗
7. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ: Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006, 7: 392–401. 10.1016/S1470-2045(06)70665-910.1016/S1470-2045(06)70665-9 ↗
8. Liang Zang J, Yuan Q, Chao Wang F, Pu Zhao Y: A comparative study of Young's modulus of single-walled carbon nanotube. Comput.Mater. Sci 2009, 46: 621–625. 10.1016/j.commatsci.2009.04.00710.1016/j.commatsci.2009.04.007 ↗
9. Favila A, Gallo M, Glossman-Mitnik D: DFT studies of functionalized carbon nanotubes and fullerenes as nanovectors for drug delivery of antitubercular compounds. J. Mol. Mod. 2007, 13: 505. 10.1007/s00894-007-0170-210.1007/s00894-007-0170-2 ↗
10. Maiti A: Adsorption of carbon monoxide on a (6,6) armchair carbon nanotube: Ab initio study. Microelec.J 2006. Article in press Article in press
11. Tserpesa KI, Papanikos P: Finite element modeling of single-walled carbon nanotubes. Composites B 2005, 36: 468–477. 10.1016/j.compositesb.2004.10.00310.1016/j.compositesb.2004.10.003 ↗
12. Kostarelos K, Bianco A, Prato M: Promises, facts and challenges for carbon nanotubes in imaging and therapeutic. Nature 2007, 2: 108.
13. Bottini M, Cerignoli F, Dawson MI, Magrini A, Rosato N, Mustelin T: Noncovalentlysilylated carbon nanotubes decorated with quantum dots. Biomacromolecules 2006, 7: 2259–2263. 10.1021/bm060203110.1021/bm0602031 ↗
14. Nakayama-Ratchford N, Bangsaruntip S, Sun X, Welsher K, Dai H: DNA wrapping and cleavage of a carbon nanotube–polypseudorotaxane conjugate. J. Am. Chem. Soc. 2007, 129: 2448–2449. 10.1021/ja068684j10.1021/ja068684j ↗
15. Bianco A, Kostarelos K, Prato M: Opportunities and challenges of carbon-based nanomaterials for cancer therapy. Expert Opin. Drug Deliv. 2008, 5: 331–342. 10.1517/17425247.5.3.33110.1517/17425247.5.3.331 ↗
16. Kam NWS, Liu Z, Dai HJ: Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing. Am. Chem. Soc. 2005, 127: 6021–6026. 10.1021/ja050062v10.1021/ja050062v ↗
17. Reed AE, Curtiss LA, Weinhold F: Intermolecular interactions from a natural bond orbital, donor-acceptor viewpoint. J. Chem. Rev. 1988, 88: 899–926. 10.1021/cr00088a00510.1021/cr00088a005 ↗
18. Yunpeng Y, Xiaoyuan C: Integrin targeting for tumor optical imaging. Theranostics 2011, 1: 102–126.10.7150/thno/v01p0102 ↗
19. Zhuang L, Tabakman S, Welsher K: Carbon nanotube in biology and medicine. Nano Res. 2009, 2: 85–120. 10.1007/s12274-009-9009-810.1007/s12274-009-9009-8 ↗
20. Wongchoosuk C, Udomvech A, Kerdcharoen T: The geometrical and electronic structures of open-end fully functionalized single-walled carbon nanotubes. J. Curr. Appl. Phys 2009, 9: 352–358. 10.1016/j.cap.2008.03.00310.1016/j.cap.2008.03.003 ↗
21. Chelmecka E, Pasterny K, Kupka T, Stobinski L: Density functional theory studies of OH-modified open ended single wall zigzag carbon nanotube (SWCNTs). J. Mol. Struct. (THEOCHEM) 2010, 948: 93–98. 10.1016/j.theochem.2010.02.02610.1016/j.theochem.2010.02.026 ↗
22. Fernandez L, Viruela-Martin P, Latorre J, Guillem C, Baltran A, Amoros P: Molecular precursors of mesostructured silica materials in the atrane route: A DFT/GIAO/NBO theoretical study. J. THEOCHEM. 2007, 822: 89–102. 10.1016/j.theochem.2007.07.02210.1016/j.theochem.2007.07.022 ↗
23. Zahedi E, Aghaie M, Zare K: Density functional study of NBO, NICS and 14N NQR parameters of 5-methylcytosine tautomers in the gas phase. J. Mol. Struct. (THEOCHEM) 2009, 905: 101–105. 10.1016/j.theochem.2009.03.01710.1016/j.theochem.2009.03.017 ↗
24. Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Montgomery JA Jr, Vreven T, Kudin KN, Burant JC, Millam JM, Iyengar SS, Tomasi J, Barone V, Mennucci B, Cossi M, Scalmani G, Rega N, Petersson GA, Nakatsuji H, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H: Gaussian 03, Revision C. 02. Wallingford, CT: Gaussian Inc; 2004.
25. Becke AD: A new mixing of Hartree-Fock and local density-functional theories. J. Chem. Phys. 1993, 98: 1372–1377. 10.1063/1.46430410.1063/1.464304 ↗
26. Padmaja L, Amalanathan M, Ravikumar C, Hubert Joe I: Density functional theory calculations and vibrational spectral analysis of 3, 5-(dinitrobenzoic acid). Spectrochim. Acta 2009, A74: 349–356.10.1016/j.saa.2009.06.007 ↗
27. Roohi H, Ebrahimi A, Habibi SM, Jarahi E: NBO and AIM analyses of the anomeric effect in fluoromethanthiol. J. Mol. Struct. (THEOCHEM) 2006, 772: 65–73. 10.1016/j.theochem.2006.06.01910.1016/j.theochem.2006.06.019 ↗
28. Nori-shargh D, Roohi F, Deyhimi F, Naeem-Abyaneh R: Conformational behaviors of trans-2,3-bis(methylthio)-1,4-dioxane, -dithiane and -diselenane. A hybrid-DFT study and NBO interpretations. J. Mol. Struct. (THEOCHEM) 2006, 763: 21–28. 10.1016/j.theochem.2006.01.01110.1016/j.theochem.2006.01.011 ↗